Insider Transactions in Q1 2021 at Endra Life Sciences Inc. (NDRA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2021
|
Michael Milos Thornton Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
18,750
-6.38%
|
$37,500
$2.37 P/Share
|
|
Feb 11
2021
|
Michael Milos Thornton Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,815
+6.72%
|
-
|
|
Jan 28
2021
|
Michael Milos Thornton Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,815
+6.72%
|
-
|
|
Jan 13
2021
|
Renaud Bertrand Maloberti Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,696
-89.66%
|
$13,696
$1.1 P/Share
|
|
Jan 12
2021
|
Renaud Bertrand Maloberti Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,304
-29.21%
|
$6,304
$1.05 P/Share
|
|
Jan 08
2021
|
Alexander Y Tokman Director |
SELL
Open market or private sale
|
Direct |
10,000
-23.33%
|
$0
$0.9 P/Share
|
|
Jan 08
2021
|
Renaud Bertrand Maloberti Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,731
-28.8%
|
$0
$0.94 P/Share
|
|
Jan 06
2021
|
Renaud Bertrand Maloberti Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,269
-27.1%
|
$0
$0.94 P/Share
|
|
Jan 06
2021
|
David R. Wells Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
34,900
-30.37%
|
$0
$0.9 P/Share
|
|
Jan 05
2021
|
David R. Wells Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.09%
|
$0
$0.9 P/Share
|